|
Less Than 3 Weeks to Register for this Complimentary Event! |
|
|
|
|
|
|
Are you coming to the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 in Amsterdam? Then be sure to join us on 3 September 2025 for this unique and innovative pre-meeting, onsite or virtually!
The 7th Liverpool Course 2025, developed by leading HIV care and pharmacology experts in collaboration with the University of Liverpool, educates participants on clinical pharmacology and drug-drug interactions critical to HIV management. It is led by the creators of the widely used Liverpool HIV drug interactions checker.
The thoughtfully curated program includes a blend of cutting-edge lectures, clinical case presentations, and lively discussion. This year's presentations include: |
|
|
|
|
|
Case Presentation - Switching Multi-Resistant PWH Off Boosted Regimens |
|
|
|
Marta Boffito, MD, PhD, FRCP, MBA
Chelsea and Westminster Hospital NHS Foundation Trust,
Imperial College London,
United Kingdom |
|
|
|
Sign up and secure your place to join renowned experts in the field of HIV care and pharmacology and update your knowledge on the latest therapy options and potential DDIs! |
Registration is complimentary for all regular delegates. |
|
|
|
|
|
|
|
|
|
The 7th Liverpool Course 2025 is being held at:
Radisson Blu Hotel, Amsterdam City Center
Rusland 17
1012 CK Amsterdam
The Netherlands |
|
|
|
|
|
 |
|
Saye Khoo, MD, PhD
Royal Liverpool University Hospital / University of Liverpool, United Kingdom |
|
|
|
|
|
|
|
|
Acknowledgment |
|
|
 |
|
The 7th Liverpool Course 2025 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity. |
|
Endorsers |
|
|
|
|
|
Related Meeting
|
|
|
 |
|
The 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs will take place as a hybrid workshop from 3-4 September 2025 in Amsterdam, the Netherlands.
Registration is open – secure your place to discuss all aspects of the optimal use of antiviral therapy, including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in underrepresented populations, post-marketing surveillance, and regulatory considerations.
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
Copyright © 2025 Virology Education BV, All rights reserved.
Our mailing address is:
Academic Medical Education, Biltstraat 106, 3572 BJ Utrecht, The Netherlands
info@amededu.com
Want to change how you receive these emails?
Click here to update your preferences.
If you wish to unsubscribe to all future newsletters, please click here.
If you have any issues with unsubscribing, please do not hesitate to contact our Data Protection Officer via dataprotection@amededu.com |
|
|
|
|
